# Tucatinib (Tukysa)

Source: https://ourhealthnetwork.com/drugs/tucatinib
Data: FDA Orange Book and OpenFDA, refreshed periodically

## What is Tucatinib?

Tucatinib (brand name: Tukysa) is a kinase inhibitor. It is prescribed to treat breast neoplasms.

## Brand names

Tukysa

## Indications

Tucatinib is primarily prescribed for the treatment of breast neoplasms.

## Conditions treated

- [Breast Neoplasms](https://ourhealthnetwork.com/conditions/breast-neoplasms)

## Mechanism of action

Tucatinib is a tyrosine kinase inhibitor of HER2.

## Drug classification

- Established Pharmacologic Class: Kinase Inhibitor [EPC]
- Mechanism of Action class: Tyrosine Kinase Inhibitors [MoA]
- Route of administration: ORAL

## Common side effects

a were diarrhea, abdominal pain, and diarrhea, and seizure, nausea, of patients were hepatotoxicity, vomiting

## Sources and disclaimers

- FDA Orange Book and OpenFDA dataset
- This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting, stopping, or changing any medication.

## Related

- [All drugs](https://ourhealthnetwork.com/drugs)
- [Find specialists who prescribe this drug](https://ourhealthnetwork.com/find-doctors)
- [Methodology](https://ourhealthnetwork.com/methodology)